By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Quintessence Biosciences, Inc. 

University Research Park
505 South Rosa Road
Madison  Wisconsin  53719  U.S.A.
Phone: 608-441-2950 Fax: 608-441-2801


SEARCH JOBS


Industry
Biotechnology






Company News
Quintessence Biosciences, Inc. Presents Human Ribonuclease Variant, QBI-139, at the American Society of Clinical Oncology Meeting 6/8/2010 11:22:55 AM
Quintessence Biosciences, Inc. Presents Efficacy Data for Conjugates of Clinical Candidate QBI-139 at Cancer Meeting 4/21/2009 1:33:51 PM
Patients Now Enrolling in Phase I Human Trial for Quintessence Biosciences, Inc. Cancer Drug, QBI-139 3/26/2009 10:46:57 AM
Quintessence Biosciences, Inc. Cancer Drug, QBI-139, Clears FDA Review to Start Phase I Human Trial 12/5/2008 2:30:43 PM
Quintessence Biosciences, Inc. Presents Efficacy Data for Next Generation Evadeā„¢ Ribonucleases at Cancer Meeting 10/23/2008 3:26:35 PM
Federal Contract Awarded to Quintessence Biosciences, Inc. Funding will Support Development of Next Generation EVade(TM) Ribonuclease Drug Candidates 10/9/2008 1:45:02 PM
Quintessence Biosciences, Inc. Presents Pre-clinical Toxicology Data at Cancer Meeting 4/14/2008 2:11:01 PM
Althea Technologies, Inc. Chosen by Quintessence Biosciences, Inc. to Produce Lead Protein Oncology Drug 2/5/2008 10:16:56 AM
Two Federal Grants Support Quintessence Biosciences, Inc. 11/30/2007 7:54:56 AM
Madison Biotechs Get Commerce Grants10/19/2005 5:13:14 PM
12
//-->